Abstract P5-05-07: A prospective, multicenter, single-arm clinical study of inetetamab combined with pyrotinib and capecitabine/vinorelbine in the treatment of HER2-positive metastatic breast cancer resistant to previous trastuzumab treatment
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Yan Xue, Junmei Zhang, Xuezheng Wang, Donghui Li, Dongmei Jiang, Yefa Gao, Xingyan Li
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411285969